Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.20
+0.03 (0.42%)
At close: Mar 9, 2026, 4:00 PM EDT
6.70
-0.50 (-6.94%)
After-hours: Mar 9, 2026, 5:10 PM EDT

Addex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
767114360
Upgrade
Market Cap Growth
14.87%-15.45%-34.64%-74.03%-28.14%34.18%
Upgrade
Enterprise Value
53202740
Upgrade
Last Close Price
7.177.006.0512.60125.80268.00
Upgrade
PE Ratio
-0.80----
Upgrade
PS Ratio
37.6613.723.827.1912.5013.73
Upgrade
PB Ratio
1.000.585.402.112.333.64
Upgrade
P/TBV Ratio
1.000.585.402.112.333.64
Upgrade
EV/Sales Ratio
23.775.661.080.287.769.20
Upgrade
Debt / Equity Ratio
0.010.000.300.080.030.04
Upgrade
Net Debt / Equity Ratio
-0.36-0.34-3.07-1.34-1.18-1.24
Upgrade
Net Debt / EBITDA Ratio
0.881.291.580.631.321.53
Upgrade
Net Debt / FCF Ratio
1.370.610.440.401.361.48
Upgrade
Asset Turnover
0.020.050.250.090.150.15
Upgrade
Quick Ratio
1.914.191.392.305.035.18
Upgrade
Current Ratio
2.014.421.462.385.315.38
Upgrade
Return on Equity (ROE)
-72.84%-90.72%-82.53%-98.92%-97.35%-64.08%
Upgrade
Return on Assets (ROA)
-15.90%-22.48%-21.69%-42.75%-45.37%-28.76%
Upgrade
Return on Capital Employed (ROCE)
-40.30%-27.90%-128.30%-210.80%-84.20%-73.90%
Upgrade
Earnings Yield
-102.10%125.46%-170.78%-200.32%-38.95%-24.15%
Upgrade
FCF Yield
-27.01%-95.57%-129.41%-158.28%-37.39%-22.99%
Upgrade
Buyback Yield / Dilution
-7.75%-32.04%-64.45%-32.43%-27.88%-0.96%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.